{
    "organizations": [],
    "uuid": "db1380606c8355d2254cb1e62395820187e83088",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-lupin-launches-generic-clobex-spra/brief-lupin-launches-generic-clobex-spray-0-05-pct-in-u-s-idUSFWN1RB05B",
    "ord_in_thread": 0,
    "title": "Lupin Launches Generic Clobex Spray, 0.05 Pct In U.S.",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 29 (Reuters) - Lupin Ltd:\n* LAUNCHES GENERIC CLOBEX SPRAY, 0.05 PERCENT IN THE US ‍​ * SPRAY IS USED FOR TREATMENT OF MODERATE TO SEVERE PLAQUE PSORIASIS AFFECTING UP TO 20 PERCENT BODY SURFACE AREA IN PATIENTS 18 YEARS OF AGE OR OLDER Source text: bit.ly/2IeyRDQ Further company coverage:\n ",
    "published": "2018-03-29T18:13:00.000+03:00",
    "crawled": "2018-03-30T12:48:01.000+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "lupin",
        "ltd",
        "launch",
        "generic",
        "clobex",
        "spray",
        "percent",
        "u",
        "spray",
        "used",
        "treatment",
        "moderate",
        "severe",
        "plaque",
        "psoriasis",
        "affecting",
        "percent",
        "body",
        "surface",
        "area",
        "patient",
        "year",
        "age",
        "older",
        "source",
        "text",
        "company",
        "coverage"
    ]
}